[Durgical](https://durgical.com/en/) › [DurgiPedia](https://durgical.com/en/durgipedia/) › [Pharmacology](https://durgical.com/en/pharmacology/) › [CDK4/6 inhibitors](https://durgical.com/en/pharmacology/classes/cdk4-6-inhibitors/) › Abemaciclib

# Abemaciclib

## CDK4/6 inhibitors?

CDK4/6 inhibitors

## High alert?

An error with this medicine can cause serious harm: double checks and protocols are used.

## Pregnancy: avoid?

Avoid in pregnancy. Can harm the fetus: a pregnancy test is done before starting, effective contraception is used during treatment and for a time afterwards (by women and by men…

A CDK4/6 inhibitor for HR-positive, HER2-negative breast cancer, with hormone therapy or alone. Its hallmark is diarrhoea, often early.

Updated Nov 1, 2026

## Quick facts

**Group**
[CDK4/6 inhibitors](https://durgical.com/en/pharmacology/classes/cdk4-6-inhibitors/)

**Target**
Cyclin-dependent kinases 4 and 6 (CDK4/6)

**Used for**
HR-positive · Advanced or metastatic HR-positive

**Key effects**
Diarrhoea · Neutropenia · Nausea

**Monitor**
Complete blood count · Liver tests

**ATC**
L01EF03

No doses: the clinician sets them by the current guideline.

On this page

- The basics Mechanism of action
- Indications
- Adverse effects
- Pharmacokinetics
- Memory aid

- Clinical What the labels mean

- Safety Contraindications
- Key interactions
- What is monitored
- Administration and safety
- Pregnancy and breastfeeding
- Nursing care

- Study Test yourself

- Connections Connections

## Mechanism of action

✂**Cyclin-dependent kinases 4 and 6 (CDK4/6)**Abemaciclib

ⓘ The figure shows abemaciclib in the ATP pocket of human CDK6.

**Target in 3D:** Cyclin-dependent kinases 4 and 6 (CDK4/6). PDB structure 5L2S (RCSB PDB, public domain). [View the structure at RCSB PDB](https://www.rcsb.org/structure/5L2S) · Drag to rotate · pinch to zoom

Abemaciclib inhibits CDK4 and CDK6, keeps Rb active and stops hormone receptor-positive breast cancer cells in G1. It is the only member of the class that is also used on its own after endocrine therapy and chemotherapy.

- Inhibits CDK4 and CDK6
- Rb stays active: G1 arrest of HR-positive cells
- With endocrine therapy, or alone after chemotherapy

## Indications

- HR-positive, HER2-negative, node-positive early breast cancer at high risk of recurrence, with tamoxifen or an aromatase inhibitor. [Breast cancer →](https://durgical.com/en/conditions/breast-cancer/)
- Advanced or metastatic HR-positive, HER2-negative breast cancer: with an aromatase inhibitor first line, with fulvestrant after endocrine therapy, or alone after endocrine therapy and chemotherapy. [Breast cancer →](https://durgical.com/en/conditions/breast-cancer/)

## Adverse effects

### Common

- Diarrhoea, very common and sometimes severe
- Neutropenia, anaemia and thrombocytopenia
- Nausea, vomiting, abdominal pain, decreased appetite
- Fatigue and infections
- Hair loss and headache

### Serious (rare, important)

- Severe diarrhoea with dehydration
- Severe neutropenia and infection
- Hepatotoxicity
- Venous thromboembolism, including pulmonary embolism
- Interstitial lung disease or pneumonitis

## Contraindications

- No absolute contraindications in the label apart from hypersensitivity; see the warnings

## Key interactions

**Strong CYP3A4 inhibitors (clarithromycin, itraconazole, ketoconazole, ritonavir) and grapefruit**
Raise abemaciclib levels; strong inhibitors are avoided.

**Strong CYP3A4 inducers (rifampicin, carbamazepine, phenytoin, St John's wort)**
Lower its levels and can make it fail.

## What is monitored

- Complete blood count
- Liver tests
- Stool frequency and hydration
- Signs of venous thrombosis (leg swelling, chest pain, breathlessness)

## Administration and safety

- Oral; swallowed whole, never split, crushed, chewed or opened.
- Grapefruit, its juice and St John's wort are avoided because they change its levels.
- An antidiarrhoeal plan is given at the start: fluids and antidiarrhoeal medicine at the first loose stool, as the doctor directs.

## Pregnancy and breastfeeding

Avoid in pregnancy. Can harm the fetus: a pregnancy test is done before starting, effective contraception is used during treatment and for a time afterwards (by women and by men with partners who could conceive), and breastfeeding is avoided.

## Nursing care

- Teach the diarrhoea plan before the first dose and how to recognise dehydration (thirst, dry mouth, little urine, fast pulse).
- Review blood counts and liver tests as ordered.
- Ask about history of blood clots; teach signs of thrombosis.
- Confirm a negative pregnancy test before the first dose and teach contraception during treatment and afterwards.

## Pharmacokinetics

**Absorption**
Oral tablets, with or without food.

**Metabolism**
Liver, CYP3A.

**Half-life**
About 18 hours.

## Memory aid

«ABEmaciclib, Always Bring an antidiarrhoeal»: the CDK4/6 inhibitor of diarrhoea, and the only one that can go solo.

## Test yourself

Think of the answer, then tap the question to see it.

## Which adverse effect is most characteristic of abemaciclib?

Diarrhoea, often early and sometimes severe.

## Which CDK4/6 inhibitor can be given without endocrine therapy?

Abemaciclib, alone after endocrine therapy and chemotherapy for metastatic disease.

## What should the patient have at home when starting abemaciclib?

An antidiarrhoeal medicine and a plan to start it, with fluids, at the first loose stool.

[Add to my cards (3)](https://durgical.app/estudiar/?add=/en/pharmacology/abemaciclib/)

[More Pharmacology questions →](https://durgical.com/en/practice/?f=pharmacology)

## What the labels mean

**High alert**
An error with this medicine can cause serious harm: double checks and protocols are used.

**Pregnancy: avoid**
Avoid in pregnancy. Can harm the fetus: a pregnancy test is done before starting, effective contraception is used during treatment and for a time afterwards (by women and by men…

## Connections

## Related drugs 3

- [Palbociclib](https://durgical.com/en/pharmacology/palbociclib/)
- [Ribociclib](https://durgical.com/en/pharmacology/ribociclib/)
- [Tamoxifen](https://durgical.com/en/pharmacology/tamoxifen/)

## Related conditions 1

- [Breast cancer](https://durgical.com/en/conditions/breast-cancer/)

[← Back to the class: CDK4/6 inhibitors](https://durgical.com/en/pharmacology/classes/cdk4-6-inhibitors/)

Educational content on how drugs work; not a prescribing guide and no substitute for a health professional's advice. No doses are given.

Sources: [Abemaciclib: MedlinePlus Drug Information](https://medlineplus.gov/druginfo/meds/a617049.html) (MedlinePlus (U.S. National Library of Medicine), 2023); [Abemaciclib - NCI](https://www.cancer.gov/about-cancer/treatment/drugs/abemaciclib) (National Cancer Institute, 2024); [ATCDDD - ATC/DDD Index](https://atcddd.fhi.no/atc_ddd_index/?code=L01EF03) (WHO Collaborating Centre for Drug Statistics Methodology, 2026).

## **Spotted a mistake?** We are always improving for the community. Tell us what is wrong and our team will review it. Report a mistake

Representative model, for educational purposes only.

---
Source: https://durgical.com/en/pharmacology/abemaciclib/
License: CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). Cite as: DurgiPedia (durgical.com), https://durgical.com/en/pharmacology/abemaciclib/
